PLYMOUTH MEETING, Pa.,
Nov. 11, 2021 /PRNewswire/
-- Harmony Biosciences Holdings, Inc.
("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated
to developing and commercializing innovative therapies for
patients with rare neurological diseases, today announced that
Harmony's President and CEO, John C.
Jacobs, will participate in fireside chats and host investor
meetings at the following upcoming virtual conferences:
- Jefferies London Healthcare Conference
-
- Fireside Chat: A pre-recorded fireside chat will be available
on-demand beginning on Thursday, November
18 at 8:00am GMT /
3:00am ET through Friday, November 19 at 5:00pm GMT / 12:00pm
ET
- 1x1 Meetings: Thursday, November 18,
2021 and Friday, November 19,
2021
- Piper Sandler 33rd Annual
Virtual Healthcare Conference
-
- Fireside Chat: A pre-recorded fireside chat will be available
on-demand beginning on Monday, November
22nd at 10:00am
ET
- 1x1 Meetings: Tuesday, November 30,
2021
The audio webcast of the fireside chats will be available on the
investor page of Harmony's website at
https://ir.harmonybiosciences.com/.
About Harmony Biosciences
Harmony Biosciences is a commercial stage pharmaceutical company
headquartered in Plymouth Meeting,
PA. The Company was established by Paragon Biosciences, LLC,
and is focused on providing novel treatment options for people
living with rare neurological diseases who have unmet medical
needs. For more information on Harmony, please visit the company's
website: www.harmonybiosciences.com.
Harmony Biosciences Investor Contact:
Patti Bank
ICR Westwicke
415-513-1284
ir@harmonybiosciences.com
Harmony Biosciences Media Contact:
Nancy Leone
215-891-6046
nleone@harmonybiosciences.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-two-investor-conferences-in-november-301421739.html
SOURCE Harmony Biosciences